| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 91.17B | 42.35B | 48.60B | 45.54B | 52.41B |
| Gross Profit | 71.36B | 42.35B | 35.76B | 34.72B | 42.25B |
| EBITDA | 58.63B | 0.00 | 13.55B | 15.35B | 20.25B |
| Net Income | 27.09B | 13.02B | 9.37B | 11.51B | 15.01B |
Balance Sheet | |||||
| Total Assets | 2.12T | 1.05T | 925.40B | 860.69B | 791.27B |
| Cash, Cash Equivalents and Short-Term Investments | 795.85B | 883.49B | 326.54B | 343.07B | 339.64B |
| Total Debt | 993.40B | 198.28B | 179.18B | 166.79B | 191.18B |
| Total Liabilities | 1.78T | 870.27B | 752.02B | 696.86B | 640.64B |
| Stockholders Equity | 320.58B | 170.78B | 166.97B | 157.70B | 147.12B |
Cash Flow | |||||
| Free Cash Flow | -44.35B | 54.95B | 6.04B | 48.95B | 9.51B |
| Operating Cash Flow | -42.75B | 56.11B | 7.20B | 50.73B | 10.37B |
| Investing Cash Flow | 180.63B | -22.66B | -26.26B | -11.52B | -33.72B |
| Financing Cash Flow | 70.82B | 7.51B | 5.94B | -34.64B | 28.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$145.10B | 10.56 | 8.83% | 0.97% | 64.00% | 112.84% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | HK$432.08B | 12.45 | 10.28% | 2.05% | 62.72% | 29.18% | |
59 Neutral | HK$152.69B | 9.05 | 9.55% | 3.83% | 51.04% | 24.56% | |
58 Neutral | HK$320.90B | 8.69 | 8.71% | 2.75% | 52.67% | 121.43% | |
57 Neutral | HK$179.38B | 10.96 | 8.46% | 2.92% | 10.82% | 55.25% | |
53 Neutral | HK$174.89B | 9.66 | 10.70% | 2.80% | 36.57% | 77.14% |